"Positive regulation of CD4-positive, alpha-beta T cell differentiation"

pathway activity — cross-omics
GO:0043372Cross-omicsRNA → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the "Positive regulation of CD4-positive, alpha-beta T cell differentiation" pathway is significantly associated with the RNA expression of multiple genes, with the LAML cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CLEC10A, ITGAX, and MYO1F, each associated with the pathway in up to 34 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, "Positive regulation of CD4-positive, alpha-beta T cell differentiation" activity versus CLEC10A in LAML (Pearson r = 0.46).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LAMLCLEC10A →+2.149+0.068<.001<.001334
SCLCITGAX →+1.876+0.134<.001<.001334
SCLCMYO1F →+1.799+0.143<.001<.001334
LAMLFGD2 →+2.410+0.102<.001<.001334
SCLCCLEC12A →+1.148+0.100<.001<.001334
CHOLGPR132 →+1.450+0.057<.001<.001334
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0043372 vs CLEC10A — LAML

Per-sample scatter of

Explore this scatter interactively →

Exploration